Literature DB >> 11144092

Complete revascularization of the left anterior descending coronary artery.

Y Nakayama1, R Sakata, M Ura, Y Arai.   

Abstract

OBJECTIVE: To assess the efficacy of complete revascularization of the left anterior descending coronary artery.
METHODS: To obtain such revascularization, 81 patients required the use of such complex techniques as the onlay patch technique or double bypasses during bypass grafting.
RESULTS: The onlay patch technique was used in 39 (48%) and double bypasses in 42 (52%). The wall motion in all anterior segments of the left ventricle showed an improving trend postoperatively. The patency rate was 99% overall, and the bypass grafts to the left anterior descending coronary artery were all patent with flow in all left anterior descending coronary artery areas. Perioperative myocardial infarction occurred in only 1 patient (1.2%), and hospital mortality was 2.5% (2/81). Long-term results of 79 hospital survivors were as follows: the mean follow-up time was 77 months (3 to 236); the actuarial survival rate including all deaths and estimated by cardiac death was 90% and 95% at the eighth postoperative year respectively; the cardiac event free rate at the fifth and eighth postoperative year was 90% and 63% respectively. A total of 8 cardiac events were observed. Excluding 3 cardiac deaths, no cardiac events were clearly attributable to the left anterior descending coronary artery.
CONCLUSIONS: Complete revascularization of the left anterior descending coronary artery using these techniques improved the anterior wall motion in the left ventricle and cardiac performance at low risk, and provided excellent long-term results.

Entities:  

Mesh:

Year:  2000        PMID: 11144092     DOI: 10.1007/BF03218239

Source DB:  PubMed          Journal:  Jpn J Thorac Cardiovasc Surg        ISSN: 1344-4964


  19 in total

1.  Revascularization of the septal artery.

Authors:  W S Stoney; R P Vernon; W C Alford; G R Burrus; C S Thomas
Journal:  Ann Thorac Surg       Date:  1976-01       Impact factor: 4.330

2.  Does mammary artery grafting increase surgical risk?

Authors:  D M Cosgrove; F D Loop; B W Lytle; M Goormastic; R W Stewart; C C Gill; L R Golding
Journal:  Circulation       Date:  1985-09       Impact factor: 29.690

3.  The left internal mammary artery: the graft of choice.

Authors:  J E Okies; U S Page; J C Bigelow; A H Krause; N W Salomon
Journal:  Circulation       Date:  1984-09       Impact factor: 29.690

4.  Late patency of the internal mammary artery as a coronary bypass conduit.

Authors:  H B Barner; M T Swartz; J G Mudd; D H Tyras
Journal:  Ann Thorac Surg       Date:  1982-10       Impact factor: 4.330

5.  Twelve-year experience with internal mammary artery for coronary artery bypass.

Authors:  H B Barner; J W Standeven; J Reese
Journal:  J Thorac Cardiovasc Surg       Date:  1985-11       Impact factor: 5.209

6.  Endarterectomy, vein patch, and mammary bypass of the anterior descending artery.

Authors:  J S Ladowski; M H Schatzlein; D J Underhill; A C Peterson
Journal:  Ann Thorac Surg       Date:  1991-11       Impact factor: 4.330

7.  Bypass surgery with the internal mammary artery graft: 15 year follow-up.

Authors:  A Cameron; H G Kemp; G E Green
Journal:  Circulation       Date:  1986-11       Impact factor: 29.690

8.  Coronary bypass surgery with internal-thoracic-artery grafts--effects on survival over a 15-year period.

Authors:  A Cameron; K B Davis; G Green; H V Schaff
Journal:  N Engl J Med       Date:  1996-01-25       Impact factor: 91.245

9.  Seventeen-year experience with bilateral internal mammary artery grafts.

Authors:  D L Galbut; E A Traad; M J Dorman; P L DeWitt; P B Larsen; P A Kurlansky; J H Button; J M Ally; T O Gentsch
Journal:  Ann Thorac Surg       Date:  1990-02       Impact factor: 4.330

10.  Results of internal thoracic artery grafting over 15 years: single versus double grafts.

Authors:  A C Fiore; K S Naunheim; P Dean; G C Kaiser; G Pennington; V L Willman; L R McBride; H B Barner
Journal:  Ann Thorac Surg       Date:  1990-02       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.